Literature DB >> 17991346

Amebic colitis: new insights into pathogenesis and treatment.

Tracy E Bercu1, William A Petri, Jr W Behm.   

Abstract

Amebiasis, caused by the protozoan parasite Entamoeba histolytica, affects more than 50 million people worldwide, with over 100,000 deaths annually. The majority of cases are asymptomatic; however, significant morbidity and mortality are associated with illness in the remaining 10% of cases. Recent advances in the understanding of the mechanism of infection by E. histolytica, the role of the innate immune system, and the role of genetic disposition to infection will allow the development of novel detection and treatment methods. The disease mechanisms, clinical findings, therapeutic strategies, and important developments regarding amebiasis are discussed here.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991346     DOI: 10.1007/s11894-007-0054-8

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  21 in total

Review 1.  Diagnosis and management of amebiasis.

Authors:  W A Petri; U Singh
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

Review 2.  Amebiasis.

Authors:  Rashidul Haque; Christopher D Huston; Molly Hughes; Eric Houpt; William A Petri
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

3.  Evaluation of Entamoeba histolytica antigen and antibody point-of-care tests for the rapid diagnosis of amebiasis.

Authors:  Megan Leo; Rashidul Haque; Mamun Kabir; Shantanu Roy; Rita Marie Lahlou; Dinesh Mondal; Egbert Tannich; William A Petri
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

4.  Caspase 3-dependent killing of host cells by the parasite Entamoeba histolytica.

Authors:  C D Huston; E R Houpt; B J Mann; C S Hahn; W A Petri
Journal:  Cell Microbiol       Date:  2000-12       Impact factor: 3.715

5.  Antibody response in intestinal and extraintestinal amebiasis.

Authors:  I M Krupp
Journal:  Am J Trop Med Hyg       Date:  1970-01       Impact factor: 2.345

6.  Entamoeba histolytica and Entamoeba dispar utilize externalized phosphatidylserine for recognition and phagocytosis of erythrocytes.

Authors:  Douglas R Boettner; Christopher D Huston; James A Sullivan; William A Petri
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

7.  Correlation of interferon-gamma production by peripheral blood mononuclear cells with childhood malnutrition and susceptibility to amebiasis.

Authors:  Rashidul Haque; Dinesh Mondal; Jianfen Shu; Shantanu Roy; Mamun Kabir; Andrea N Davis; Priya Duggal; William A Petri
Journal:  Am J Trop Med Hyg       Date:  2007-02       Impact factor: 2.345

8.  Epidemiology of amebiasis in a region of high incidence of amebic liver abscess in central Vietnam.

Authors:  Joerg Blessmann; Pham Van Linh; Phuong Anh Ton Nu; Hao Duong Thi; Bertram Muller-Myhsok; Heidrun Buss; Egbert Tannich
Journal:  Am J Trop Med Hyg       Date:  2002-05       Impact factor: 2.345

9.  Transcriptional and secretory responses of Entamoeba histolytica to mucins, epithelial cells and bacteria.

Authors:  Anjan Debnath; Jessica S Tashker; Mohammed Sajid; James H McKerrow
Journal:  Int J Parasitol       Date:  2007-02-12       Impact factor: 3.981

10.  Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin.

Authors:  Eric Houpt; Lisa Barroso; Lauren Lockhart; Rhonda Wright; Carole Cramer; David Lyerly; William A Petri
Journal:  Vaccine       Date:  2004-01-26       Impact factor: 3.641

View more
  29 in total

1.  Relapse of intestinal and hepatic amebiasis after treatment.

Authors:  Elizabeth W Hwang; Lawrence Cheung; Amirkaveh Mojtahed; Christine A Cartwright
Journal:  Dig Dis Sci       Date:  2010-12-14       Impact factor: 3.199

Review 2.  Chew on this: amoebic trogocytosis and host cell killing by Entamoeba histolytica.

Authors:  Katherine S Ralston
Journal:  Trends Parasitol       Date:  2015-06-09

Review 3.  New insights on classification, identification, and clinical relevance of Blastocystis spp.

Authors:  Kevin S W Tan
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 4.  The green vaccine: A global strategy to combat infectious and autoimmune diseases.

Authors:  Abdoreza Davoodi-Semiromi; Nalapalli Samson; Henry Daniell
Journal:  Hum Vaccin       Date:  2009-07-23

5.  A novel, multi-parallel, real-time polymerase chain reaction approach for eight gastrointestinal parasites provides improved diagnostic capabilities to resource-limited at-risk populations.

Authors:  Rojelio Mejia; Yosselin Vicuña; Nely Broncano; Carlos Sandoval; Maritza Vaca; Martha Chico; Philip J Cooper; Thomas B Nutman
Journal:  Am J Trop Med Hyg       Date:  2013-03-18       Impact factor: 2.345

6.  Amoebic colitis: A case series of a recurring missed diagnosis.

Authors:  Joshua Haron Abasszade; Robert Little; Fiona Yeaman; Marcus Robertson; Sally Bell
Journal:  JGH Open       Date:  2020-12-22

7.  Lipids induce expression of serum-responsive transmembrane kinase EhTMKB1-9 in an early branching eukaryote Entamoeba histolytica.

Authors:  Shiteshu Shrimal; Arpita Saha; Sudha Bhattacharya; Alok Bhattacharya
Journal:  Sci Rep       Date:  2012-03-26       Impact factor: 4.379

8.  Antiamoebic drugs for treating amoebic colitis.

Authors:  Maria Liza M Gonzales; Leonila F Dans; Juliet Sio-Aguilar
Journal:  Cochrane Database Syst Rev       Date:  2019-01-09

9.  Serosurvey of Entamoeba Histolytica Exposure among Tepehuanos Population in Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Jesús Hernández-Tinoco; Luis Francisco Sánchez-Anguiano; Agar Ramos-Nevárez; Sandra Margarita Cerrillo-Soto; Carlos Alberto Guido-Arreola
Journal:  Int J Biomed Sci       Date:  2015-06

10.  Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis.

Authors:  A M Jarrad; A Debnath; Y Miyamoto; K A Hansford; R Pelingon; M S Butler; T Bains; T Karoli; M A T Blaskovich; L Eckmann; M A Cooper
Journal:  Eur J Med Chem       Date:  2016-04-27       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.